Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Lomvastomig for Solid Cancers
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new cancer treatment that targets two proteins, PD-1 and TIM-3. The trial will first test different doses to find the best one, then test it on different types of cancer to see if it is effective.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.